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SUMMARY
African trypanosomes have emerged as promising unicellular model organisms for the next generation of systems biology.
They oﬀer unique advantages, due to their relative simplicity, the availability of all standard genomics techniques and a
long history of quantitative research. Reproducible cultivation methods exist for morphologically and physiologically
distinct life-cycle stages. The genome has been sequenced, and microarrays, RNA-interference and high-accuracy me-
tabolomics are available. Furthermore, the availability of extensive kinetic data on all glycolytic enzymes has led to the early
development of a complete, experiment-based dynamic model of an important biochemical pathway. Here we describe the
achievements of trypanosome systems biology so far and outline the necessary steps towards the ambitious aim of creating a
‘Silicon Trypanosome’, a comprehensive, experiment-based, multi-scale mathematical model of trypanosome physiology.
We expect that, in the long run, the quantitative modelling enabled by the Silicon Trypanosome will play a key role in
selecting the most suitable targets for developing new anti-parasite drugs.
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THE AMBITION OF SYSTEMS BIOLOGY
Systems biology seeks to understand how functional
properties of living systems, such as biological
rhythms, cellular diﬀerentiation or the adaptation of
organisms to changes in their environment, emerge
from interactions between the components in the
underlying molecular networks (Bruggeman and
Westerhoﬀ, 2007). In the case of parasites with
multiple hosts, diﬀerentiation and adaptation to
drugs may be particularly relevant. Current systems
biology is to a large extent (but not exclusively)
focused on single-cell systems.These aremore amen-
able to global molecular analysis than multicellular
organisms. This is partly because high-throughput
post-genomic technologies (transcriptomics, pro-
teomics and metabolomics) make it relatively easy to
measure many components of a homogeneous popu-
lation of cells simultaneously. Furthermore, dynamic
measurements of the response of a cell population to
a shared stimulus allow insight into the functional
connectivity between components (Richard et al.
1996; Hynne et al. 2001; Nikerel et al. 2006, 2009;
Schmitz et al. 2009).
Mathematical methods that enable quantitative
descriptions of the dynamic interplay between the
molecules in living cells are being developed and, for
the ﬁrst time, it is possible to envisage a comprehen-
sive molecular description of the functional circuitry
of cellular systems. The Silicon Cell project (Snoep
et al. 2006; Westerhoﬀ et al. 2009) involves an in-
ternational consortium of researchers aiming at a
mathematical description of life at the cellular level
on the basis of complete and quantitative genomic,
transcriptomic, proteomic, metabolomic and pheno-
typic information. So far, the most ambitious whole-
cell modelling eﬀorts have targeted the model
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organisms Escherichia coli and Saccharomyces cere-
visiae. The advanced state of understanding and the
enormous amount of data relating to these organisms
have made them obvious candidates for such a com-
prehensive description. Yet, the variety of organisms
in the ‘JWS Online’ model repository (www.jjj.bio.
vu.nl) demonstrates that the silicon cell initiative is
not limited to these organisms.
THE UNIQUE ADVANTAGES OF TRYPANOSOME
SYSTEMS BIOLOGY
The African trypanosome, Trypanosoma brucei, the
causative agent of human African trypanosomiasis
and Nagana cattle disease (Barrett et al. 2003), has
emerged as a front runner in systems biology analy-
sis. The relative simplicity of the energy metabolism
of its bloodstream form and the early availability of a
comprehensive and uniform set of kinetic data of the
enzymes involved, were crucial factors for the suc-
cessful construction of a detailed computer model of
trypanosome glycolysis (Bakker et al. 1997). The
obvious questions for this model were initially in the
realm of drug-target selection; the ﬁrst studies analy-
sed in depth how sensitive the pathway overall would
be to varying extents of inhibition of each enzyme
(Bakker et al. 1999a). Another important factor sti-
mulating further development of trypanosome sys-
tems biology was the possibility of reproducible
in vitro cultivation, ﬁrst of the procyclic insect stage,
but later also of the long slender bloodstream form
(Hirumi and Hirumi, 1989; Haanstra, 2009). Tran-
sitions between distinct life-cycle stages can be stud-
ied in a tractable and synchronous diﬀerentiation
system (Fenn and Matthews, 2007). Moreover, the
complete genome of T. brucei has been sequenced
and annotated, and ametabolic pathway database has
been developed (Berriman et al. 2005; Chukualim
et al. 2008).
An extension of the scope of trypanosome systems
biology to include gene expression is facilitated by
the absence of transcriptional regulation in trypano-
somes. This implies that, unlike in most other
organisms, the gene-expression cascade is regulated
only post-transcriptionally. The genes of African
trypanosomes – as well as those of the other kineto-
plastids – are arranged in polycistronic transcription
units which can be hundreds of kilobases long
(Berriman et al. 2005; Siegel et al. 2009). All evidence
so far indicates that RNA polymerase II transcribes
constitutively, without intervention of regulatory
factors (Lee et al. 2009; Palenchar and Bellofatto,
2006). Individual mRNAs are excised by a trans-
splicing complex which places identically capped 39
nt leaders at the 5k end of every mRNA (Liang et al.
2003); this splicing is co-ordinated with polyadenyl-
ation of the RNA located immediately upstream.
Indeed, regulation of mRNA biogenesis may well be
restricted to the processing steps (Lustig et al. 2007;
Stern et al. 2009), while steady-state levels are further
inﬂuenced by the rate of mRNA degradation
(Clayton and Shapira, 2007). In fact, the majority of
evidence concerning regulation of gene expression
has implicated mRNA decay as the dominant factor
(Clayton and Shapira, 2007; Haanstra et al. 2008b),
and this is the only step for which mechanistic details
of the regulation are available.
After the complete sequencing of the trypanosome
genome (Berriman et al. 2005), mRNA microarray
analyses of the diﬀerentiation from the blood-
stream to the procyclic form have demonstrated
that the expression of whole sets of mRNAs is co-
ordinately regulated (Queiroz et al. 2009). When
gene-expression is studied during synchronous
diﬀerentiation, accurate time proﬁles of extremely
homogenous cell populations can be obtained
(Kabani et al. 2009). Most results so far suggest that
such regulation is mediated by RNA-binding pro-
teins that bind to speciﬁc sequences in the 3k-
untranslated regions of mRNAs (Archer et al. 2009;
Clayton and Shapira, 2007; Este´vez, 2008). The rate
of mRNA translation and protein turnover are other
factors inﬂuencing the steady-state protein levels.
Here too, key regulatory proteins have been ident-
iﬁed (Paterou et al. 2006; Walrad et al. 2009).
MILESTONES OF TRYPANOSOME
SYSTEMS BIOLOGY
A quantitative mathematical model of energy metab-
olism in the long slender form of the trypanosome
(i.e. the form that replicates in the mammalian
bloodstream) has been developed (Bakker et al. 1997)
and iteratively updated after experimental testing
(Bakker et al. 1999a, b ; Albert et al. 2005; Haanstra
et al. 2008a). This model yields quantitative pre-
dictions of the ﬂux through glycolysis, the concom-
itant ATP production ﬂux, and the concentrations of
glycolytic metabolites, at steady state as well as fol-
lowing a perturbation. Input data for the model are
kinetic equations and parameters of enzymes and
their concentrations. Through this model, the eﬀects
of drugs on the glycolytic pathway can be assessed
quantitatively starting from their eﬀects on the in-
dividual enzymes.
Free-energy metabolism in the bloodstream form
of T. brucei has been a logical starting point for the
‘bottom-up’ construction of a ‘Silicon Trypano-
some’. Bloodstream forms of the parasite depend
exclusively on substrate-level phosphorylation for
ATP production through glycolysis, which proceeds
as far as pyruvate (Flynn andBowman, 1973) (Fig. 1).
Pyruvate is the end product and is secreted from the
cell.Many of the glycolytic enzymes diﬀer in terms of
allosteric regulation from their mammalian counter-
parts, and this probably relates to the fact that in
T. brucei the ﬁrst seven enzymes of the pathway re-
side within membrane-bounded, peroxisome-like
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organelles called glycosomes (Opperdoes and Borst,
1977; Parsons, 2004; Michels et al. 2006; Haanstra
et al. 2008), which isolate most of the glycolytic
pathway from the rest of the metabolic network in-
volved in consumption of ATP and NAD(H). Even
in growing and dividing trypanosomes, virtually all
glucose is converted to pyruvate, as the amount re-
quired for biosynthesis is quantitatively negligible
(Haanstra, 2009). This ﬁnding supports the initial
choice to model the glycolytic pathway without any
branches other than the one to glycerol. Glycerol
production is crucial under anaerobic conditions
(Fairlamb et al. 1977).
Since the publication of the ﬁrst version of the
glycolysis model (Bakker et al. 1997), there have been
two major updates (Helfert et al. 2001; Albert et al.
2005). Both of these involved updates and extensions
of the enzyme kinetic dataset, e.g. the explicit in-
clusion of individual enzymes that were previously
grouped into a net multi-step conversion. In the
second update (Albert et al. 2005) the enzyme ex-
pression levels (Vmax) were adapted to reﬂect the
concentrations observed in trypanosomes obtained
from controlled state-of-the-art in vitro cultivation.
Key missing pieces of information remain the mech-
anism and kinetics of the transport of glycolytic
metabolites across the glycosomal membrane. The
identiﬁcation of semi-selective pores in peroxisomal
membranes suggests that the smaller metabolites
equilibrate across the glycosomal membrane, while
bulkier molecules like ATP or NADH require spe-
ciﬁc transporters (Grunau et al. 2009; Rokka et al.
2009). This idea justiﬁes, with hindsight, the choice
to model the transport of a number of small inter-
mediates as rapid-equilibrium processes.
A number of basic and applied biological questions
have been addressed using the glycolysis model. For
example, it was predicted and then experimentally
conﬁrmed (Bakker et al. 1999a, b) that the uptake of
glucose across the plasmamembrane was amajor ﬂux
controlling step and therefore an interesting drug
target. Enzymes that have been suggested to control
glycolysis in mammalian cells, like hexokinase, phos-
phofructokinase and pyruvate kinase (Schuster and
Holzhu¨tter, 1995), exerted little control in trypano-
somes, according to the model (Bakker et al. 1999a ;
Albert et al. 2005). Experiments, in which the ex-
pression of these enzymes was knocked down, con-
ﬁrmed this prediction qualitatively. However, the
enormous overcapacity of some enzymes, which was
predicted by the model, was shown to be exaggerated
(Albert et al. 2005). This suggests that there are in
vivo regulation mechanisms aﬀecting these enzymes
in a currently unknown fashion. Protein phosphoryl-
ation may contribute, since a glycosomal phospha-
tase has been identiﬁed in developmental signalling
(Szoor and Matthews, unpublished data). The inhi-
bition of anaerobic glycolysis by glycerol was also
reproduced by the model, ﬁrst qualitatively and then
quantitatively (Bakker et al. 1997; Albert et al. 2005).
An interesting biological feature that was revealed
by the model was the relationship between compart-
mentation of glycolysis in glycosomes and the virtual
absence of allosteric regulation of the glycolytic en-
zymes. Glycolysis models predict that glycolytic in-
termediates accumulate readily due to the investment
of ATP at the beginning of the pathway (Teusink
et al. 1998; Bakker et al. 2000). This risky ‘turbo’
eﬀect can be avoided either by allosteric feedback
Fig. 1. The glycolytic pathway in Trypanosoma brucei.
Reaction numbers indicate: 1. glucose transport ;
2. hexokinase; 3. phosphoglucose isomerase;
4. phosphofructokinase ; 5. aldolase; 6. triose-phosphate
isomerase; 7. glyceraldehyde-3-phosphate
dehydrogenase; 8. phosphoglycerate kinase;
9. phosphoglycerate mutase; 10. enolase; 11. pyruvate
kinase; 12. pyruvate transport ; 13. glycerol-3-phosphate
dehydrogenase; 14. glycerol-3-phosphate oxidase
(a combined process of mitochondrial glycerol-3-
phosphate dehydrogenase and trypanosome alterative
oxidase; 15. glycerol kinase; 16. combined ATP
utilization; 17. glycosomal adenylate kinase; 18. cytosolic
adenylate kinase. Question marks indicate
uncharacterized transport processes. Abbreviations of
metabolite names: Glc-6-P: glucose 6-phosphate;
Fru-6-P: fructose 6-phosphate; Fru-1,6-BP: fructose
1,6-bisphosphate; DHAP: dihydroxyacetone phosphate;
Gly-3-P: glycerol 3-phosphate; GA-3-P: glyceraldehyde
3-phosphate; 1,3-BPGA: 1,3-bisphosphoglycerate ;
3-PGA: 3-phosphoglycerate ; 2-PGA:
2-phosphoglycerate ; PEP: phospho-enolpyruvate.
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regulation of hexokinase or by compartmentation
of the pathway in glycosomes (Fig. 2). Compart-
mentation prevents the accumulation of inter-
mediates, because the net ATP production occurs
outside the glycosome and this excess of ATP cannot
activate the ﬁrst enzymes of glycolysis. This model
prediction was recently conﬁrmed experimentally
(Haanstra et al. 2008a), providing a clear example
of model-driven experimental design and hypoth-
esis-driven systems biology. According to model
predictions the glycolytic intermediates glucose 6-
phosphate, fructose 6-phosphate and fructose-
1,6-bisphosphate should accumulate on addition of
glucose if the glycolytic enzymes are not properly
located in the glycosome. Indeed, accumulation of
glucose 6-phosphate could be measured in a PEX14-
RNAi mutant in which protein import into the
glycosomes is disturbed. A similar phenotype was
observed on glycerol addition, which led to accumu-
lation of glycerol 3-phosphate, both in the model and
in the PEX14-RNAi cells. Also in accordance with
model predictions, a down-regulation of the ex-
pression of the genes encoding hexokinase and
glycerol kinase rescues the PEX14-RNAi cells on
glucose and glycerol, respectively (Kessler and
Parsons, 2005; Haanstra et al. 2008a).
More recently, a model of the gene-expression
cascade, based on quantitative knowledge of tran-
scription,RNAprecursor degradation, trans-splicing
and mRNA degradation for phosphoglycerate kinase
(PGK) has been generated (Haanstra et al. 2008b).
The model allowed a quantitative analysis of the
control and regulation of the expression of the PGK
isoenzymes. It was shown that regulation of mRNA
degradation explains 80–90% of the regulation of
mature mRNA levels, while precursor degradation
and trans-splicing make only minor contributions.
In spite of the success of the model, it covers to
date only a small part of trypanosome metabolism.
This relates, for instance, to the fact that even the
compartmentalised glycolysis does branch into other
pathways, for example towards the biosynthesis of
glycoconjugates and the pentose phosphate pathway.
Although the ﬂuxes into these branches may be
small, they are vital for trypanosomes. Suﬃcient
kinetic data have become available to enable exten-
sion of the model to include the pentose phosphate
pathway which provides NADPH for reductive
biosyntheses and also reducing equivalents to sustain
cellular redox balance. Since redox balance is inti-
mately related to the biosynthesis of trypanothione
(from polyamine and glutathione precursors), a
natural next step in a bottom-up systems biology
approach to trypanosome metabolism would be the
inclusion of the trypanothione–pentose phosphate
pathway and related areas of redox metabolism
(Fig. 3).
GROWTH STAGES OF BUILDING A SILICON
TRYPANOSOME
Our current level of knowledge of trypanosome re-
dox metabolism, as well as its biological importance
(Krauth-Siegel and Comini, 2008), render it a
natural choice for a next model extension (Fig. 3).
The inclusion of redox metabolism is particularly
Fig. 2. A. The positive feedback from the ATP produced by glycolysis to the initial kinase reactions can lead to toxic
accumulation of hexose phosphates. In many organisms this is prevented by a negative feedback from the hexose
phosphates to hexokinase. B. In trypanosomes, the compartmentation of glycolysis prevents the positive feedback. This
renders the negative feedback unnecessary, and indeed there is no evidence for such feedback in trypanosomes.
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interesting as trypanosome redox metabolism is
suﬃciently diﬀerent from its human counterpart to
oﬀer perspectives for drug discovery. The unusual
polyamine–glutathione conjugate trypanothione or
bis(glutathionyl)spermidine (Fairlamb and Cerami,
1992) takes on the majority of roles served by glu-
tathione inmost other cell types. In addition, work in
the last few years revealed that the enzymes involved
in the synthesis and reduction of trypanothione are
essential for the parasite (Krauth-Siegel and Comini,
2008).
The trypanocidal drug eﬂornithine exerts its
trypanocidal activity as an irreversible inhibitor of
the enzyme ornithine decarboxylase (Bacchi et al.
1980), an enzyme involved in trypanothione biosyn-
thesis (enzyme 10 in Fig. 3). A signiﬁcant amount
of information is available on kinetic parameters of
that pathway, too. Preliminary attempts to model
trypanothione metabolism have been made (Xu Gu,
University of Glasgow PhD thesis, unpublished).
Information available on the abundance of key
metabolites measured in bloodstream form T. brucei
grown in vitro (Fairlamb et al. 1987) and in vivo (Xiao
et al. 2009), before and after exposure to eﬂornithine,
was used to determine whether predicted behaviour
under those perturbed conditions emulated the
measured behaviour. The scarcity of kinetic data
describing the whole pathway, however, has pre-
sented many challenges to constructing a model that
captures observed behaviour. The acquisition of new
kinetic data and the implementation of new math-
ematical tools to ﬁll gaps in the data (Nikerel et al.
2006; Smallbone et al. 2007; Resendis-Antonio,
2009) should improve this.
An extension of the glycolysis model to include the
pentose phosphate pathway (Hanau et al. 1996;
Barrett, 1997; Duﬃeux et al. 2000) and trypa-
nothionemetabolism should be a suitable next step in
the modular approach that we envisage towards a
complete Silicon Trypanosome. Initial eﬀorts in this
direction (not published) have indicated the im-
portance of the compartmentation of the pentose
phosphate pathway. Although most of the en-
zymes of the pathway have a peroxisome targeting
Fig. 3. The glycolytic and trypanothione pathways are linked through the oxidative pentose phosphate pathway.
Metabolites are presented in abbreviated form within rectangles. Enzymes and transporters are circles. Kinetic data is
available for those shaded grey. Met=methionine; Arg=arginine; Gly=glycine; Glu=glutamate; Cys=cysteine;
ATP=adenosine triphosphate; SAM=S-adenosylmethionine; dcSAM=decarboxylated S-adenosylmethionine;
MTA=methylthioadenosine; Orn=ornithine; Put=putrescine; Spd=spermidine; c-GC=c-glutamylcysteine;
GSH=glutathione; GSpd=glutathionylspermidine; T(SH2)=reduced trypanothione; TS2=oxidised trypanothione;
NADP=nicotinamide adenine dinucleotide phosphate; NADPH=reduced nicotinamide adenine dinucleotide
phosphate; Glc=glucose; G6P=glucose 6-phosphate; Ru5P=ribulose 5-phosphate; Ox=oxidised cellular
metabolites ; Red=reduced cellular metabolites. 1.=methionine transport; 2.=arginine transport ; 3.=glycine
transport; 4.=glutamate transport ; 5=cysteine transport; 6.=methionine adenosyltransferase; 7.=arginase
(N.B., a robust arginase gene orthologue has not been annotated in the T. brucei genome project, raising the possibility
that arginine does not serve as a source of ornithine in these cells) ; 8.=S-adenosylmethionine decarboxylase;
9.=prozyme; 10.=ornithine decarboxylase; 11.=spermidine synthase; 12.=c-glutamylcysteine synthetase;
13.=glutathione synthetase; 14.=c-glutathionylspermidine synthetase; 15.=trypanothione synthetase/amidase
(in T. brucei 14. & 15. are catalysed by a single protein) ; 16.=trypanothione reductase; 17. oxidative pentose phosphate
pathway (glucose 6-phosphate dehydrogenase, 6-phopshogluconolactonase & 6-phosphoglconate dehydrogenase) ;
18.=glucose transporter; 19.=hexokinase (this enzyme links the redox pathway to glycolysis) ; 20.=pyruvate
transporter; 21.=methionine cycle enzymes; 22. The pathway of electrons from reduced trypanothione for ﬁnal
acceptance on oxidised cellular metabolites or macromolecules is complex, involving transfers via other redox active
intermediates including tryparedoxin (thioredoxin-like proteins) and peroxidoxin.
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sequence (PTS1), a signiﬁcant fraction of their ac-
tivity is often found in the cytosol (Michels et al.
2006; Heise and Opperdoes, 1999; Duﬃeux et al.
2000). A correct localisation of the enzymes as well as
good estimates of the transport of intermediates
across the glycosomal membrane will be key to a
good model of the pentose phosphate pathway.
CHALLENGES OF TRYPANOSOME
SYSTEMS BIOLOGY
The ﬁrst initiatives in systems biology of trypano-
somes as well as of other organisms dealt with en-
zymatic sub-systems, such as glycolysis. The models
have depended largely on kinetic data for isolated
enzymes. However, the abundance of these enzymes
can, in principle, be controlled by the rates of tran-
scription, RNA processing, translation, protein
modiﬁcation and turnover. These processes them-
selves may be regulated through complex signalling
networks in response to both internal and external
conditions (Westerhoﬀ et al. 1990).
To include gene expression in a Silicon Try-
panosome requires a dramatic increase in model
complexity – as well as the acquisition of new types
of data on a large scale. Fortunately, the absence of
transcriptional control of most individual open
reading frames makes trypanosome gene expression
simpler than that of yeast or even E. coli, rendering it
uniquely amenable to mathematical modelling.
It may well be possible to describe much of
trypanosomemRNAmetabolism using the following
parameters : the rate constant of processing of the
precursor RNA, i.e. of trans-splicing; the rate con-
stant of degradation of the precursor (which com-
petes with its trans-splicing) ; the rate constant of
polyadenylation; and the rate constant of mRNA
degradation. The rates of degradation of the pre-
cursor and the mature mRNA can be measured by
inhibiting splicing and transcription. Tomeasure the
rate of mRNA processing two approaches are poss-
ible. First, one can inhibit transcription alone, and
assay precursor decay; this approach is, however,
compromised by practical constraints since splicing
is very rapid. Second, the splicing rate can be cal-
culated based on the steady-state abundance of the
precursor mRNA, and the half-life and abundance of
the products. This methodology has already been
applied to the mRNA encoding PGK and it was
demonstrated that splicing occurred within less than
one minute; mRNA decay was the primary deter-
minant of mRNA abundance (Haanstra et al. 2008b).
Previous microarray studies with yeast have
yielded estimates of the half-lives and polysomal
loading of many mRNAs (e.g. Grigull et al. 2004).
Deep sequencing technology – being more sensi-
tive – should allow measurement of the abundances
of all mRNAs and precursors on a genome-wide scale
and to the accuracy required for the modelling; from
these data, it should be possible to derive the steady-
state abundances andhalf-lives of allRNAs, revealing
regulated or ineﬃcient processing. This – combined
with global polysome proﬁling – will provide quan-
titative data which allow quantifying the regulation
of the processing, degradation and translation of
each mRNA (Daran-Lapujade et al. 2007). The next
challenge would then be to integrate such measure-
ments with metabolic modelling in order to provide
a complete model of pathways, from DNA to meta-
bolic end-products.
ANTICIPATED OUTCOMES FROM
A SILICON TRYPANOSOME
So far, the systems biology approach to trypanosomes
has contributed to a fundamental understanding
of cellular regulation (Bakker et al. 1999a ; Haanstra
et al. 2008a), as well as to improvements in the drug-
target selection process (Bakker et al. 1999a, b ;
Albert et al. 2005; Hornberg et al. 2007). Since the
initial systems biology analysis only addressed pro-
cesses associated with less that 1% of the organism’s
genome, we would expect manymore new insights to
lie ahead.
Drugs currently used against human African
trypanosomiasis are unsatisfactory for a number of
reasons, including their extreme adverse eﬀects in
the patient and the emergence of resistant parasites.
New drugs are urgently needed and there is hope that
a better understanding of the control points of the
metabolic network can guide the selection of optimal
drug targets. This has already been achieved for
enzymes of the glycolytic pathway (Hornberg et al.
2007). This information can be used alongside
enhanced chemoinformatics (Frearson et al. 2007)
in order to determine those components of the
trypanosome that are most amenable to drug tar-
geting.
As a consortium we have embarked on the con-
struction of a Silicon Trypanosome. In this review
we have discussed the current status and future di-
rections of trypanosome systems biology that form
the context of this endeavour. Our ambition is to
achieve a comprehensive, quantitative description of
the ﬂow of information from gene, through transcript
and protein, to metabolism and back. This will allow
prediction of how the parasite responds to changes in
its environment, with respect to nutrients, tempera-
ture and/or chemical inhibitors. It will also assist
the deciphering of complex phenotypes generated
by genetic perturbations in the laboratory or in the
ﬁeld. Thus, model predictions will improve our
biological understanding of the diﬀerentiation and
adaptation of the parasite as well as stimulate the
discovery of inhibitors that attack processes which
control trypanosome growth. The latter should con-
tribute to the development of new optimised drugs
for trypanocidal chemotherapy. Pioneering eﬀorts
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have focused on energy metabolism and recently
started to include adaptations of the parasite via gene
expression (Haanstra, 2009).
The construction of a complete Silicon Trypano-
some, which integrates metabolism, gene expression
and signal transduction is an ambitious project.
Clearly the route towards this objective will be long,
and many challenges will emerge as the datasets re-
quired to build such a model are collected and analy-
sed. However, the emergence of methods to allow
collection of massive datasets, at every level, suggests
that we may, in time, be able to generate a reasonably
complete mathematical description of trypanosome
cellular biology. Even if completion is not feasible,
the evolving description will always represent the
best conceivable dynamic representation of our
knowledge of trypanosome biology. As a result, drug
development programmes will have at their disposal
a predictive model of the trypanosome to help iden-
tify those parts of metabolism most amenable to
targeting by novel drugs and to controlling vital func-
tions of the parasite. The project will be strengthened
by parallel world-wide systems biology projects of
human metabolism, in which some of us will be in-
volved. After all, killing trypanosomes is easy. The
diﬃculty is to kill the trypanosome without harming
its host (Bakker et al. 2002). A careful comparison
of the behaviour of our Silicon Trypanosome to
quantitative knowledge of the control of human
metabolism, will allow the identiﬁcation of selective
targets.
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